Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Politics

HHS slams ‘under-tested’ mRNA technology as Trump cuts Moderna’s vaccine funding

by admin May 29, 2025
May 29, 2025
HHS slams ‘under-tested’ mRNA technology as Trump cuts Moderna’s vaccine funding

President Donald Trump’s Department of Health and Human Services (HHS) is terminating awards totaling more than $750 million dollars that were provided to pharmaceutical manufacturer Moderna to help facilitate its production of mRNA-based bird flu vaccines. 

During President Joe Biden’s final week in office, his administration awarded $590 million to Moderna to help speed up its production of mRNA-based vaccines. The $590 million award followed a separate $176 million award Biden gave to Moderna earlier last year for mRNA vaccine technology.

Messenger RNA vaccines are a newer type of vaccine technology, which was utilized by companies like Moderna and Pfizer to develop their COVID-19 vaccines. The vaccine technology was at the center of a lot of criticism amid the coronavirus pandemic for potentially being associated with adverse side effects in some people who took them, such as myocarditis.

Trump administration officials previously hinted at the potential that this funding could be terminated, citing a lack of oversight during the Biden administration pertaining to vaccine production. 

‘After a rigorous review, we concluded that continued investment in Moderna’s H5N1 mRNA vaccine was not scientifically or ethically justifiable,’ HHS Communications Director Andrew Nixon said. ‘This is not simply about efficacy — it’s about safety, integrity, and trust. The reality is that mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimate safety concerns from the public.’

The announcement reflects a larger shift in federal vaccine priorities, after HHS Secretary Robert F. Kennedy Jr. announced earlier this week that COVID-19 vaccines would be removed from the federal government’s list of recommended vaccines for children and pregnant women. 

Meanwhile, a report from Senate Republicans released earlier this month suggested the Biden administration withheld critical safety data and downplayed known risks tied to the mRNA COVID-19 vaccine. In particular, the Senate report focuses on HHS’ awareness of, and response to, cases of myocarditis — a type of heart inflammation — following COVID-19 vaccination.

‘Rather than provide the public and health care providers with immediate and transparent information regarding the risk of myocarditis following mRNA COVID-19 vaccination, the Biden administration waited until late June 2021 to announce changes to the labels for the Moderna and Pfizer COVID-19 vaccines based on the ‘suggested increased risks’ of myocarditis and pericarditis,’ the Senate report states. ‘Even though CDC and FDA officials were well aware of the risk of myocarditis following COVID-19 vaccination, the Biden administration opted to withhold issuing a formal warning to the public for months about the safety concerns, jeopardizing the health of young Americans.’

In response to the Trump administration’s funding termination, Moderna put out a press release acknowledging the move, but also touting the ‘safety profile’ observed amid its work on a new mRNA bird flu vaccine.

‘While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program,’ said Stéphane Bancel, Chief Executive Officer of Moderna. ‘These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats.’

Fox News Digital’s Brooke Singman contributed to this report.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Purepoint Announces Amendment of Omnibus Equity Incentive Compensation Plan
next post
Israeli ambassador slams UN’s ‘mafia-like’ tactics against US-backed Gaza foundation

Related Posts

Crunch time: Harris to team up with Barack...

October 18, 2024

Schumer refuses to step down as Senate Dem...

March 24, 2025

Israel Defense Forces will receive hostages Sunday with...

January 19, 2025

Moscow returns body of Ukrainian journalist killed in...

May 1, 2025

House lawmakers leave DC until September with government...

July 27, 2024

Speaker Johnson announces new Capitol bathroom policy in...

November 21, 2024

Inside Trump’s urgent meeting with House GOP to...

May 21, 2025

Burgum grilled on environmental issues targeted by Trump...

January 17, 2025

Here are the greatest Inauguration Day moments in...

January 18, 2025

Republicans fixated on Epstein are getting ‘duped’ by...

July 17, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Key aide in IRS’ Tea Party targeting controversy put on leave after allegations of new anti-GOP effort

      August 6, 2025
    • Supreme Court orders new arguments in pivotal elections case

      August 6, 2025
    • Michelle Obama celebrates Barack as ‘coolest guy’ on his birthday after the pair joked about divorce rumors

      August 6, 2025
    • Senate GOP ready to go nuclear after Schumer’s ‘political extortion’ of nominees

      August 6, 2025
    • Cotton calls on IRS to pull Muslim advocacy group’s nonprofit status

      August 6, 2025

    Categories

    • Business (1,052)
    • Investing (2,769)
    • Politics (3,407)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved